Agenda
  • SEP 12, 2018 06:00 AM PDT
    Speaker: Jennifer Gardy, PhD
  • SEP 12, 2018 06:00 AM PDT
    Speaker: Amy Pruden, PhD
  • SEP 12, 2018 07:30 AM PDT
    Speaker: Vera Tesic, MD, MS, D (ABMM), M (ASCP)
  • SEP 12, 2018 09:00 AM PDT
    Speaker: Haley Appaneal, Pharm D.
  • SEP 12, 2018 09:00 AM PDT
    Speaker: Karissa Culbreath, PhD, D(ABMM)
    Sponsored By: DiaSorin
  • SEP 12, 2018 10:30 AM PDT
    Speaker: Brian Eddie, PhD
  • SEP 12, 2018 10:30 AM PDT
    Speaker: Jack Gilbert, PhD
    Sponsored By: Illumina
  • SEP 12, 2018 10:30 AM PDT
    Speaker: Vladimir Vidanovic, MD
  • SEP 12, 2018 12:00 PM PDT
    Speaker: Winnie Ridderberg, PhD
    Sponsored By: QIAGEN
  • SEP 12, 2018 12:00 PM PDT
    Speaker: Mohammad Qadir, PhD
  • SEP 12, 2018 12:00 PM PDT
    Speaker: Sean Conlan, PhD
  • SEP 12, 2018 01:30 PM PDT
    Speaker: Lucy Williams, PhD
    Sponsored By: QIAGEN
  • SEP 12, 2018 01:30 PM PDT
    Speaker: Julie Russell, PhD
  • SEP 13, 2018 06:00 AM PDT
    Speaker: Siobain Duffy, PhD
  • SEP 13, 2018 06:00 AM PDT
    Speaker: Joseph Petrosino, PhD
  • SEP 13, 2018 07:30 AM PDT
    Speaker: Patrick McDermott, MS, PhD
  • SEP 13, 2018 09:00 AM PDT
    Sponsored By: QIAGEN
    Matthew Fosbrink, PhD
    Scientist BRC Product Development, QIAGEN
    Dominic O'Neil
    Director Microbiome Product Development, QIAGEN
  • SEP 13, 2018 09:00 AM PDT
    Speaker: Laura Zinke, PhD
  • SEP 13, 2018 10:30 AM PDT
    Speaker: Ann Stevens, PhD
  • SEP 13, 2018 10:30 AM PDT
    Speaker: Allison Lopatkin, PhD
  • SEP 13, 2018 12:00 PM PDT
    Speaker: Joan Chow, MPH, DrPH
  • SEP 13, 2018 12:00 PM PDT
    Speaker: James Galen, PhD
  • SEP 13, 2018 12:00 PM PDT
    Speaker: Rusty Rodriguez, PhD
  • SEP 13, 2018 01:30 PM PDT
    Speaker: Terence Crofts, PhD
  • SEP 13, 2018 01:30 PM PDT
    Speaker: Jonas Korlach, PhD
    Sponsored By: PacBio
  • Infectious Diseases
  • SEP 12, 2018 06:00 AM PDT
    Speaker: Jennifer Gardy, PhD
  • SEP 12, 2018 07:30 AM PDT
    Speaker: Vera Tesic, MD, MS, D (ABMM), M (ASCP)
  • SEP 12, 2018 09:00 AM PDT
    Speaker: Karissa Culbreath, PhD, D(ABMM)
    Sponsored By: DiaSorin
  • SEP 12, 2018 10:30 AM PDT
    Speaker: Vladimir Vidanovic, MD
  • SEP 12, 2018 12:00 PM PDT
    Speaker: Sean Conlan, PhD
  • SEP 12, 2018 01:30 PM PDT
    Speaker: Lucy Williams, PhD
    Sponsored By: QIAGEN
  • Applied Microbiology
  • SEP 12, 2018 06:00 AM PDT
    Speaker: Amy Pruden, PhD
  • SEP 12, 2018 10:30 AM PDT
    Speaker: Brian Eddie, PhD
  • SEP 12, 2018 12:00 PM PDT
    Speaker: Winnie Ridderberg, PhD
    Sponsored By: QIAGEN
  • SEP 13, 2018 06:00 AM PDT
    Speaker: Joseph Petrosino, PhD
  • SEP 13, 2018 07:30 AM PDT
    Speaker: Patrick McDermott, MS, PhD
  • SEP 13, 2018 12:00 PM PDT
    Speaker: Rusty Rodriguez, PhD
  • Ecology & Evolution
  • SEP 12, 2018 09:00 AM PDT
    Speaker: Haley Appaneal, Pharm D.
  • SEP 12, 2018 10:30 AM PDT
    Speaker: Jack Gilbert, PhD
    Sponsored By: Illumina
  • SEP 13, 2018 09:00 AM PDT
    Speaker: Laura Zinke, PhD
  • SEP 13, 2018 10:30 AM PDT
    Speaker: Ann Stevens, PhD
  • SEP 13, 2018 01:30 PM PDT
    Speaker: Terence Crofts, PhD
  • Emerging Trends in Obtaining and Analyzing Samples
  • SEP 12, 2018 12:00 PM PDT
    Speaker: Mohammad Qadir, PhD
  • SEP 13, 2018 10:30 AM PDT
    Speaker: Allison Lopatkin, PhD
  • SEP 13, 2018 01:30 PM PDT
    Speaker: Jonas Korlach, PhD
    Sponsored By: PacBio
  • New Methods and Emerging Trends
  • SEP 12, 2018 01:30 PM PDT
    Speaker: Julie Russell, PhD
  • SEP 13, 2018 09:00 AM PDT
    Sponsored By: QIAGEN
    Matthew Fosbrink, PhD
    Scientist BRC Product Development, QIAGEN
    Dominic O'Neil
    Director Microbiome Product Development, QIAGEN
  • SEP 13, 2018 12:00 PM PDT
    Speaker: Joan Chow, MPH, DrPH
  • Virulence and Vaccinations
  • SEP 13, 2018 06:00 AM PDT
    Speaker: Siobain Duffy, PhD
  • SEP 13, 2018 12:00 PM PDT
    Speaker: James Galen, PhD
SEP 12 - 13 2018

Microbiology and Immunology 2018

Our 4th Annual Microbiology and Immunology Virtual Conference is now available On Demand!

Participants will explore and discover new concepts, tools and techniques to apply to ongoing research and diagnostics. Microbiology and Immunology cover an array of industries and disciplines, encompassing various research areas including pharmaceuticals, medicine, agriculture, and space. The development of new techniques and the ability to sequence organisms without the need to grow them in the laboratory has opened up a new world of microbial diversity and complexity we know little about.

With the progress made toward learning more about the world of microbiology and disease, the need for more rapid diagnosis, increased standardization of testing and greater adaptability to manage threats from newly evolved infectious microorganisms will become more and more apparent. The combination of the new tools being developed along with advancements in basic knowledge can lead to profound changes and growth in Microbiology and Immunology.
 

Topic's for this years event included: 

  • Infectious Diseases
  • Developments in Virology, Virulence and Vaccinations.
  • New Methods and Emerging Trends
  • Ecology & Evolution
  • Applied Microbiology


Our virtual conference allows you to participate in a global setting with no travel or cost to you. You can participate in exactly those parts which you are interested in and be back at your desk or bench in an instant. This virtual conference also offers increased reach for the global microbiology community with a high degree of interaction through live-streaming video and chat sessions.

Don't forget to participate in our Leaderboard and Scavenger Hunt to win one of our Free Science T-shirts!  

Continuing Education
By participating in this virtual event and watching webcast presentations, you can earn Free Continuing Education (PACE). To earn educational credits, you must view an entire presentation. Following the presentation, you must click on the educational credit link provided for that particular speaker and follow the required process. Once you have completed the process, you will receive a certificate for the educational credit.



 

Use #LRmicro to follow the conversation!

 


Speakers
  • Assistant Professor of Pathology, Assistant Director of Clinical Microbiology and Immunology Laboratories, The University of Chicago Medicine
  • Director, The National Antimicrobial Resistance Monitoring System, Office of Research, Center for Veterinary Medicine, Food & Drug Administration
  • Research Health Scientist, Providence VA Medical Center
  • Chief, Surveillance, Epidemiology, Assessment & Evaluation Section Sexually Transmitted Disease Control Branch California Department of Public Health
  • Associate Investigator, Microbial Genomics Section, National Institutes of Health (NIH)
  • Pathology and Immunology Postdoctoral Scholar, Dantas Lab, Washington University in St. Louis
  • Medical Director, Infectious Disease, Tricore Reference Laboratories, Associate Professor, Department of Pathology, University of New Mexico School of Medicine
  • Associate Professor, Department of Ecology, Evolution & Natural Resources, Rutgers University
  • Research Biologist, Center for Bio/Molecular Science and Engineering, Naval Research Laboratory
  • Scientist BRC Product Development, QIAGEN
  • Professor, Center for Vaccine Development, University of Maryland Baltimore
  • Assistant Professor, Canada Research Chair in Public Health Genomics, Senior Scientist (Genomics), BC Centre for Disease Control, The University of British Columbia
  • Faculty Director, The Microbiome Center, Professor, Department of Surgery, The University of Chicago
  • Chief Scientific Officer, Pacific Biosciences
  • Postdoctoral Scholar, Massachusetts Institute of Technology (MIT), Broad Institute of MIT and Harvard
  • Director Microbiome Product Development, QIAGEN
  • Professor and Interim Chairman, Baylor College of Medicine
  • Professor of Civil & Environmental Engineering, Associate Dean and Director of Interdisciplinary Graduate Education, Virginia Tech
  • President & Chief Scientific Officer, Fusion Genomics
  • Senior Scientist, Microbial Genomics, QIAGEN
  • CEO, Adaptive Symbiotic Technologies
  • Head of Culture Collections, National Infection Service, Public Health England (PHE)
  • Professor of Microbiology, Department of Biological Sciences, Virginia Tech
  • Assistant Professor of Clinical Pathology, University of Illinois at Chicago
  • Senior Bioinformatics Scientist, QIAGEN
  • Post Doctoral Researcher, University of California Davis

Show Resources
You May Also Like
SEP 14, 2016 06:30 AM PDT
C.E. CREDITS
SEP 14, 2016 06:30 AM PDT
An industry leader in delivering instrument systems, reagents, and services to life science researchers,Beckman Coulter Life Sciences helps enable new discoveries in biology-based research...
NOV 02, 2016 06:00 AM PDT
C.E. CREDITS
NOV 02, 2016 06:00 AM PDT
The 7th annual Clinical Diagnostics & Research conference is now On Demand!  This premiere venue discusses the latest advances in clinical diagnostics, research and medicine. The con...
NOV 08, 2017 06:00 AM PST
C.E. CREDITS
NOV 08, 2017 06:00 AM PST
LabRoots invites you to the 8th annual Clinical Diagnostics & Research free online conference! Clinical diagnostics is an ever-changing field of medicine and research, challenged wit...
MAY 28, 2014 06:00 AM PDT
C.E. CREDITS
MAY 28, 2014 06:00 AM PDT
This year will be our 5th annual Clinical Diagnostics & Research online conference. Attendees can earn free CME and CE Credits. The theme of this conference is a range of medical and clin...
NOV 11, 2015 06:00 AM PST
C.E. CREDITS
NOV 11, 2015 06:00 AM PST
Welcome to LabRoots’ 6th Annual Clinical Diagnostics & Research free online conference! The event is now available on-demand and you can attend sessions including keynotes...
FEB 22, 2017 06:00 AM PST
C.E. CREDITS
FEB 22, 2017 06:00 AM PST
Precision Medicine 2017 was a success and is now availabe On Demand!Imagine receiving a full diagnosis from a simple blood test, or the ability to tailor the perfect treatment to your ind...
Posters

POSTER SUBMISSION GUIDELINES

Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer reviewed. Submission is free.

SUBMIT YOUR ABSTRACT

Enter the following information to this Submission Form:

  • Poster Title
  • Your Name
  • Your Institution
  • Your Email
  • Abstract describing the poster

All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.

If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.

Questions? Email Posters@LabRoots.com

LabRoots Policy

Speakers

  • Vera Tesic, MD, MS, D (ABMM), M (ASCP)
    Assistant Professor of Pathology, Assistant Director of Clinical Microbiology and Immunology Laboratories, The University of Chicago Medicine
    Biography
      Vera Tesic, MD, MS, D (ABMM), works as an assistant professor of pathology and assistant medical director of clinical microbiology and immunology laboratories, at the University of Chicago Medicine, Chicago, Illinois. She completed her training in pathology at the University of Illinois at Chicago, followed by a fellowship in clinical microbiology at the University of Utah, ARUP Laboratories. Her areas of interest include application of new technologies into clinical laboratory practice and implementation of cost effective diagnostic tests for infectious diseases, with a particular focus on syphilis testing.
    • Patrick McDermott, MS, PhD
      Director, The National Antimicrobial Resistance Monitoring System, Office of Research, Center for Veterinary Medicine, Food & Drug Administration
      Biography
        Dr. Patrick McDermott is Director of the National Antimicrobial Resistance Monitoring System (NARMS) at the Food & Drug Administration. NARMS was established in 1996 and is an interagency collaborative effort between the FDA, USDA and CDC that tracks antibiotic resistance in bacteria from retail meats, food producing animals and human clinical cases of infection. He led studies to develop the first standardized antimicrobial susceptibility testing methods for Campylobacter, conducted work to show the impact of antimicrobials in animals, and coordinated the implementation of whole genome sequencing into NARMS national surveillance. His collaborative work aims to understand the mechanisms of antimicrobial resistance in foodborne microorganisms, how they emerge and spread, and the impact of interventions designed to limit resistance in food animal production. He is a fellow of the American Academy of Microbiology, and recipient of the FDA's Francis Kelsey award for excellence and courage in protecting the public health.
      • Haley Appaneal, Pharm D.
        Research Health Scientist, Providence VA Medical Center
        Biography
          Dr. Appaneal is a clinician scientist with expertise in infectious diseases, antibiotic stewardship, and pharmacy practice (Pharm D). She completed a pharmacy practice residency at the Providence Veterans Affairs Medical Center in July 2012 and subsequently a two-year VA funded post-doctoral fellowship for PharmDs in July 2014. Her fellowship training was in ID clinical outcomes with a focus on the appropriate use and safety of antibiotics. Since completing her fellowship, Dr. Appaneal has been a health services investigator at Providence VAMC with the Rhode Island ID (RIID) Research Program and a core member of the Providence VAMC's Antimicrobial Stewardship Program. Her research focuses in improving the quality of patient care nationally through reduction of inappropriate antibiotic use.
        • Joan Chow, MPH, DrPH
          Chief, Surveillance, Epidemiology, Assessment & Evaluation Section Sexually Transmitted Disease Control Branch California Department of Public Health
          Biography
            Dr. Chow has been a Specialist with The University of California, San Francisco, School of Medicine and with the California Department of Public Health-Sexually Transmitted Disease Control Branch since 1997. Her areas of interest have been in evaluation of new chlamydia diagnostic technologies, surveillance for reproductive health complications including pelvic inflammatory disease associated with chlamydia infections in women, chlamydia and gonorrhea prevalence monitoring in family planning populations, development of chlamydia/gonorrhea screening guidelines, and evaluation of quality improvement interventions aimed at increasing chlamydia screening, and other STD quality measures.
          • Sean Conlan, PhD
            Associate Investigator, Microbial Genomics Section, National Institutes of Health (NIH)
            Biography
              Dr. Sean Conlan is an associate investigator in the Microbial Genomics Section (MGS) of the Translational and Functional Genomics Branch at NHGRI. He oversees bioinformatics for the MGS and splits his time between data management responsibilities and basic research. The MGS uses a variety of DNA sequencing strategies and platforms to answer basic research questions on a) the human skin microbiome and b) hospital associated pathogens. Dr. Conlan works closely with the NIH Intramural Sequencing Center to process, analyze and publicly deposit sequencing data associated with MGS projects. He also does basic research on the mechanisms of antibiotic resistance, plasmid biology and molecular epidemiology of hospital associated pathogens.
            • Terence Crofts, PhD
              Pathology and Immunology Postdoctoral Scholar, Dantas Lab, Washington University in St. Louis
              Biography
                Dr. Crofts is currently a post-doctoral scholar at Washington University in St. Louis working with Dr. Gautam Dantas. One focus of his research has been the metabolic fate of antibiotics in the environment, a project that ties together antibiotic resistance and bacterial metabolism. A second focus is how early life antibiotic therapy alters the developing human gut microbiota in infants as well as the host immune system using a gnotobiotic mouse model I have developed. A third focus has been studying how the human microbiome interacts with pharmaceuticals and other xenobiotics, with a focus on the mechanisms underlying drug toxicity. Prior to this he received his Ph.D. in Microbiology from the University of California, Berkeley, working with Dr. Michi Taga studying how bacterial producers of vitamin B12 analogs use enzyme-substrate specificity to avoid incorporating incorrect lower ligands from their environment. He began his career earning joint B.S. degrees in Molecular and Cellular Biology and Chemistry from the University of Illinois, where he completed an honor's research project on T-cell receptor specificity in the lab of Dr. David Kranz. He is looking forward to starting next fall at Northwestern University as a Research Assistant Professor, where he will continue to focus on understanding how the gut microbiota affects the efficacy and toxicity of pharmaceuticals, including small molecules and biologics, as well as study how microbiota in the environment respond to and modify/degrade antimicrobials.
              • Karissa Culbreath, PhD, D(ABMM)
                Medical Director, Infectious Disease, Tricore Reference Laboratories, Associate Professor, Department of Pathology, University of New Mexico School of Medicine
                Biography
                  Dr. Culbreath earned her PhD at Vanderbilt followed by a fellowship in Medical and Public Health Microbiology at University of North Carolina Chapel Hill. Dr. Culbreath joined Tricore Reference Laboratories in Albuquerque New Mexico in 2010. Since 2011, she has served as Medical Director at Tricore and additionally since 2013 as Associate Professor, Department of Pathology University of New Mexico Health Sciences Center.
                • Siobain Duffy, PhD
                  Associate Professor, Department of Ecology, Evolution & Natural Resources, Rutgers University
                • Brian Eddie, PhD
                  Research Biologist, Center for Bio/Molecular Science and Engineering, Naval Research Laboratory
                • Matthew Fosbrink, PhD
                  Scientist BRC Product Development, QIAGEN
                  Biography
                    Matthew Fosbrink joined QIAGEN in 2009 and is currently a scientist within BRC product development. Matthew received his Ph.D. in Toxicology from University of Maryland, Baltimore where he studied cell signaling and cell cycle activation induced by complement C5b-9. After graduation, he went onto postdoctoral studies at Johns Hopkins School of Medicine where he engineered FRET-based kinase biosensors. At QIAGEN, he is the lead scientist for Targeted Microbial NGS products and Microbial DNA PCR products.
                  • James Galen, PhD
                    Professor, Center for Vaccine Development, University of Maryland Baltimore
                    Biography
                      For over 15 years, Dr. Galen has focused on the construction of attenuated bacterial vaccines and their use as live vectors to deliver foreign antigens to the immune system. His work has had broad applications to the development and pre-clinical testing of a variety of live vaccines against both eukaryotic and prokaryotic pathogens, including the etiological agents for malaria, SARS, plague, anthrax, tetanus, enteric fever, and most recently infections caused by Clostridium difficile. Dr. Galen has been involved in instrumental research on the development of plasmid-based expression systems for delivery of foreign antigens from both prokaryotic and eukaryotic organisms. He has invented two novel systems: - Antigen transport system for export of antigens out to the surface of attenuated S. Typhi. - Plasmid stabilization and selection system that removes the need for plasmid selection using antibiotics and guarantees plasmid retention in vivo after introduction into live vector strains. Dr. Galen's work has resulted in multiple patents issued in both the United States and abroad. Recent efforts have focused on the design and development of novel vaccines and therapeutic treatments against enteric disease caused by Clostridium difficile. On the vaccine side, Dr. Galen has worked on the development of a live oral vaccine designed to elicit toxin neutralizing antibodies against the three known toxins of C. difficile: Toxin A (TcdA), toxin B (TcdB), and binary toxin (CDT). On the therapeutic treatment side, he is collaborating on a unique project to engineer a probiotic strain of yeast called Saccharomyces boulardii to efficiently and stably deliver in situ therapeutically relevant levels of a novel tetravalent neutralizing antibody against CDI enterotoxins TcdA and TcdB, to interrupt recurrent disease.
                    • Jennifer Gardy, PhD
                      Assistant Professor, Canada Research Chair in Public Health Genomics, Senior Scientist (Genomics), BC Centre for Disease Control, The University of British Columbia
                      Biography
                        Dr. Jennifer Gardy is both a scientist and a science communicator. In her scientific life, she's a Senior Scientist in Genomics at the BC Centre for Disease Control and an Assistant Professor in the Faculty of Medicine at the University of British Columbia, where she holds a Canada Research Chair in Public Health Genomics. Jennifer's lab uses genome sequencing to understand how infectious diseases spread in populations. When she's not studying microbes, Jennifer works in science media. She regularly hosts episodes of CBC Television's long-running science documentary series The Nature of Things, appears as a guest host and contributor on Discovery Chanel's nightly science newsmagazine Daily Planet, and is a frequent guest on many other programs. She wrote a children's book about microbes for OwlKids Books in 2014, and regularly speaks to science graduate students about how to communicate their research effectively.
                      • Jack Gilbert, PhD
                        Faculty Director, The Microbiome Center, Professor, Department of Surgery, The University of Chicago
                        Biography
                          Jack Gilbert is the Faculty Director of the Microbiome Center, a Professor in the Department of Surgery at the University of Chicago Medicine, Senior Scientist (Adjunct) at Marine Biological Laboratory, and Group Leader in Microbial Ecology at Argonne National Laboratory. Gilbert's research is focused on the ecology, evolution, and metabolic dynamics of microbial ecosystems from myriad environments including built environments, oceans, rivers, soils, air, plants, animals, and humans. His primary interest is in using omics technologies (metagenomics, metatranscriptomics, metabolomics) to capture longitudinal dynamics in microbial ecosystems and then model how these interactions relate the environmental variables, be those variables disease onset and immunology in humans or chemical transformations in plants and soils. Gilbert is developing unifying principles which govern how microbial communities assemble. He founded the Earth Microbiome Project, and co-founded the American Gut Project, and is the editor-in-chief of the journal mSystems.
                        • Jonas Korlach, PhD
                          Chief Scientific Officer, Pacific Biosciences
                          Biography
                            Jonas Korlach was appointed Chief Scientific Officer of Pacific Biosciences in July 2012. He was previously a Scientific Fellow, supporting commercial development of the PacBio RS II system and performing research aimed at developing new applications for SMRT technologies. He co-invented the SMRT technology with Stephen Turner, Ph.D., Pacific Biosciences Founder and Chief Technology Officer, when the two were graduate students at Cornell University. Dr. Korlach joined Pacific Biosciences as the company's eighth employee in 2004. Previously, he was a Postdoctoral Researcher at Cornell University. Dr. Korlach is the recipient of multiple grants, an inventor on 70 issued U.S. patents and 61 international patents, and an author of over 70 scientific studies on the principles and applications of SMRT technology, including publications in Nature, Science, and PNAS. In 2013, Dr. Korlach was honored by the Obama White House as an Immigrant Innovator "Champion of Change." He received both his Ph.D. and his M.S. degrees in Biochemistry, Molecular and Cell Biology from Cornell, and received M.S. and B.A. degrees in Biological Sciences from Humboldt University in Berlin, Germany.
                          • Allison Lopatkin, PhD
                            Postdoctoral Scholar, Massachusetts Institute of Technology (MIT), Broad Institute of MIT and Harvard
                            Biography
                              Allison J. Lopatkin, PhD, works as a Postdoctoral Fellow in the Institute for Medical Engineering and Sciences at the Massachusetts Institute of Technology and the Infectious Disease and Microbiome group at the Broad Institute of MIT and Harvard, as a member of the Collins Lab. She completed her PhD training in Biomedical Engineering at Duke University, and her BS training in Applied Mathematics at the University of Rochester. Allison's work uses quantitative methods to study the spread of antibiotic resistance within bacterial populations, including synthetic biology approaches and mathematical modeling. Her current research interests include evolutionary dynamics of bacterial communities, leveraging horizontal gene transfer to target pathogens, and adjuvant discovery to extend the efficacy of existing antibiotics.
                            • Dominic O'Neil
                              Director Microbiome Product Development, QIAGEN
                              Biography
                                Dominic O'Neil has more than 20 years of experience in the biotechnology industry. Dominic joined Digene in Gaithersburg, MD (now QIAGEN) in 2004 to work on new technology research and development, focusing in particular on sample preparation in diagnostic applications. In 2011, he joined the QIAGEN R&D group in Germany. In 2014 he assumed responsibility for new DNA extraction technologies, where he led a team to launch multiple new products for extraction of DNA from FFPE, stool, tissue, and plasma/serum, as well as managing the R&D integration of MO BIO technologies into the QIAGEN portfolio. Currently, he leads the Microbiome Product Development group as the Director of the team overseeing new product development for the microbiome field.
                              • Joseph Petrosino, PhD
                                Professor and Interim Chairman, Baylor College of Medicine
                                Biography
                                  Joseph F. Petrosino, PhD, is an Associate Professor of Molecular Virology and Microbiology at Baylor College of Medicine and the Director of the Alkek Center for Metagenomics and Microbiome Research. He holds joint appointments in the Human Genome Sequencing Center, Department of Ophthalmology, and is a member of the Cell and Molecular Biology and Translational Biology and Molecular Medicine programs. He obtained his undergraduate degree in microbiology and immunology with a distinction in research from the University of Rochester, followed by a PhD degree in microbiology and immunology from Baylor College of Medicine. He completed postdoctoral fellowship training in genetics at Baylor College of Medicine and was a Research Associate in the Human Genome Sequencing Center working on the functional genomics of biodefense and emerging infectious disease. He was hired as a tenure-track faculty member at BCM in 2006 with a National Institute of Allergies and Infectious Diseases funded Career Development Award Project from the Western Regional Center of Excellence for Biodefense and Emerging Infectious Disease. His ongoing comparative genomics studies of Francisella tularensis, a pathogenic bacterium with the potential to pose a severe threat to public health and safety, have helped move the field closer to the goal of creating new rationally-designed attenuated and/or subunit vaccines for this Category A select agent. In 2007, Dr. Petrosino and his colleagues obtained funding through the NIH Common Fund for the Human Microbiome Project (HMP). As a large-scale sequencing center Principal Investigator for the HMP, Dr. Petrosino assisted in the lead of consortium efforts for standardized clinical sample preparation, sequencing, and analysis. This allowed microbial communities from diverse body sites and niches to be compared with minimal technical bias and has led to study design standards that are being implemented internationally. As a result of the success of his efforts and to extend metagenomics and microbiome studies at BCM, the Alkek Center for Metagenomics and Microbiome Research (CMMR) was established in January 2011, with Dr. Petrosino serving as its Director. Currently, the CMMR is pursuing over 200 metagenomics projects in humans and model systems with the goal to improve human health through detection and modulation of the microbes that reside on and in us and to translate these efforts into new diagnostics and therapeutics. Among the latest CMMR projects initiated is an $11.8M microbiome analysis of 18,000+ Type 1 Diabetes samples from the NIH/NIDDK TEDDY (The Environmental Determinants of Diabetes in the Young) study. Dr. Petrosino has authored 40 original papers. Among 14 published in 2012 are the June HMP flagship manuscripts in Nature, collaborative studies examining microbiome associations with Cystic Fibrosis, pregnancy, nutritional intervention in colitis, rotavirus infection, and the shaping of the microbiome from birth in murine systems. He has been an invited to speak at numerous institutions and meetings nationally and internationally, and recently he has been named an American Society for Microbiology Distinguished Lecturer for 2012-2014.
                                • Amy Pruden, PhD
                                  Professor of Civil & Environmental Engineering, Associate Dean and Director of Interdisciplinary Graduate Education, Virginia Tech
                                  Biography
                                    Amy Pruden is the W. Thomas Rice Professor of Civil and Environmental Engineering at Virginia Tech. Her research focuses on bringing a microbial ecological perspective to understanding and advancing design and management of environmental systems. Pruden is a leading expert on water-based pathogens and antibiotic resistance. In 2012-2013, she led a Water Research Foundation expert workshop and report on Opportunistic Pathogens in Premise Plumbing: Epidemiology, Microbial Ecology, and Engineering Controls, in which a multi-stakeholder framework for public health protection was developed. In 2016, she co-organized a workshop sponsored by the Alfred P. Sloan Foundation at Emory University, From Watersheds to Showerheads: Improving Legionella Risk Management in the 21st Century. Her current research, funded by The Alfred P. Sloan Foundation, focuses on how engineering design shapes the composition of the microbiome of tap water and implications for control and spread of Legionella, Naegleria fowleri, and antibiotic resistance genes. She has authored over 120 peer-reviewed scientific journal articles and is currently PI on a USDA AFRI project aimed at developing computational tools for identifying critical control points for mitigating the spread of antibiotic resistance. Dr. Pruden is the recipient of the Presidential Early Career Award in Science and Engineering and the Paul L. Busch Award for innovation in water research. She holds a B.S. in biology and a Ph.D. in environmental science, both from the University of Cincinnati.
                                  • Mohammad Qadir, PhD
                                    President & Chief Scientific Officer, Fusion Genomics
                                    Biography
                                      Dr Qadir's training is in genetics and molecular biology. Dr Qadir has over 17 years of research experience. The last ten were at the British Columbia Cancer Agency where he worked with world-renowned experts in genomics and drug development. Dr Qadir is the co-inventor of the CHILDSeq-Sarcoma assay and CHILDDecode (part of FUSIONCloud™). Dr Qadir oversees all the scientific aspects of research and development efforts at FUSION GENOMICS and also serves as the interface for all collaborators.
                                    • Winnie Ridderberg, PhD
                                      Senior Scientist, Microbial Genomics, QIAGEN
                                      Biography
                                        Winnie Ridderberg, a microbiologist, received her doctoral degree from Aarhus University, Denmark. Winnie has almost a decade's experience in clinical microbiology, from working at the Department of Clinical Microbiology at Aarhus University Hospital. Winnie's primary research interest has been the microbiology of cystic fibrosis with specific focus on bacterial evolution and microbiome studies. Winnie joined QIAGEN Bioinformatics in early 2017 as a research scientist at the Microbial Genomics team.
                                      • Rusty Rodriguez, PhD
                                        CEO, Adaptive Symbiotic Technologies
                                        Biography
                                          For the past 25 years Rusty has been a leading expert in plant-fungal symbiosis while effectively managing research laboratories in academic and government institutions. He is a leading expert in plant-fungal symbiosis and is commonly asked to speak at scientific conferences around the globe. Based on his scientific expertise, successes in management and knowledge of the agriculture industry, Rusty was a natural fit for CEO. He provides the great leadership and innovative thinking that keeps us on the leading edge of science in agriculture.
                                        • Julie Russell, PhD
                                          Head of Culture Collections, National Infection Service, Public Health England (PHE)
                                          Biography
                                            Julie joined the UK's Public Health Laboratory Service in 1990 after working for a few years in clinical diagnostic microbiology laboratories within the National Health Service. Initially she developed and organised proficiency testing schemes for food microbiology, then later her role expanded to include water microbiology. Organisational change meant that she now works for Public Health England and from 2012 has been the Head of Culture Collections, a biological resource centre with global reach. She studied for her first degree in Manchester, higher degree at the University of Surrey and has particular interest in the preservation of bacteria and in scientific communication.
                                          • Ann Stevens, PhD
                                            Professor of Microbiology, Department of Biological Sciences, Virginia Tech
                                            Biography
                                              Dr. Ann Stevens is a Professor of Molecular Microbiology at Virginia Tech in Blacksburg, VA. She earned her Ph.D. in 1993 from the Dept. of Microbiology at the University of Illinois at Urbana-Champaign in the laboratory of Dr. Abigail Salyers. For the next four years, she served as a postdoctoral research associate at the University of Iowa under the supervision of Dr. E. Peter Greenberg. In 1997, she began a faculty position at Virginia Tech in the Department of Biological Sciences as an assistant professor and was promoted with tenure to associate professor in 2004 and full professor in 2010. Research in her laboratory is focused on environmental sensing and response as it relates to bacterial quorum-sensing systems and bacterial-host interactions. Model organisms under investigation include the plant pathogen Pantoea stewartii and the human/animal pathogen Vibrio parahaemolyticus. Dr. Stevens was a National Science Foundation CAREER award recipient. She has received the Virginia Tech Alumni and Wine Teaching Awards and is a member of the Virginia Tech Academies of Teaching Excellence and of Faculty Service.
                                            • Vladimir Vidanovic, MD
                                              Assistant Professor of Clinical Pathology, University of Illinois at Chicago
                                              Biography
                                                He is the director of Coagulation and director of Point-of-Care Testing at University of Illinois Hospital and Health Sciences System in Chicago, and Blood Bank/Transfusion Medicine attending physician in the same institution. From 2015-2017 he held the position of Interim Director of Clinical Pathology. He is also the Laboratory Medical Director at Shriners Hospital for Children in Chicago.
                                              • Lucy Williams, PhD
                                                Senior Bioinformatics Scientist, QIAGEN
                                                Biography
                                                  Dr. Williams is a Senior Bioinformatician at Omicsoft. Her responsibilities include product development as well as customer relations for Qiagen's DiseaseLand, GeneticsLand, and OncoLand products. Prior to OmicSoft, Dr. Williams was an Assistant Professor in the Department of Genetics at the University of North Carolina in Chapel Hill, NC. She did her post-doctoral training at the National Institute of Environmental Health Sciences, where she used genetics and genomics to study how transcriptional responses are fine-tuned for proper innate immune responsiveness. She also received her PhD in Molecular Genetics at the University of North Carolina and has a BS in Biochemistry and Genetics from Texas A&M University.
                                                • Laura Zinke, PhD
                                                  Post Doctoral Researcher, University of California Davis
                                                  Biography
                                                    Laura Zinke is a viral and microbial ecologist, with a specialty in environmental systems. A Texas native, she received her BS in Biology from Texas A&M University in 2013. She then pursued a PhD in Biological Sciences at the University of Southern California (USC). While at USC, she studied the relationships between microbial ecology and geochemistry in marine sediments under the advisement of Drs. Jan Amend and Brandi Kiel Reese. This work led her to the tropical Pacific Ocean and the Baltic Sea, where she participated in research cruises (no swimsuits required). Currently, Laura is a postdoctoral researcher in Dr. Joanne Emerson's viral ecology lab at the University of California, Davis. She currently investigates viral communities in agricultural soils and how these communities impact living entities and abiotic soil properties.
                                                  Sponsored By

                                                  For information on becoming a sponsor or exhibitor, please click here.


                                                  C.E. Credits

                                                  The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


                                                  Committee

                                                  To download the Program Committee brochure here.


                                                  • Tony Rook, MS

                                                    Tony A. Rook leads the Microbiology Resource Center at The Sherwin-Williams Company in Cleveland, OH, USA, where he has built a world-class Microbiology Center of Excellence to focus on global preservation strategies, continuous improvement of industrial hygiene practices, and ...

                                                    See more See less
                                                  • Ivan Brukner, PhD

                                                  • Philip Geis, PhD

                                                  • Clyde Schultz, PhD

                                                  • Radhakrishna Tirumalai, PhD

                                                    Radhakrishna Tirumalai, PhD US Pharmacopeial Convention Dr. Tirumalai has been at the USP since 2003 and is currently a Principal Scientific Liaison in the Global Science and Standards Division. He is the Staff Liaison to the USP Expert Committees on Microbiology, and Toxicology ...

                                                    See more See less
                                                  • Emily Hollister, PhD

                                                    Dr. Hollister is a microbial ecologist and bioinformaticist. She is interested in quantifying and characterizing microbial communities from a wide variety of environments, including the human body. Utilizing high throughput, next-generation DNA and RNA sequence approaches, her ...

                                                    See more See less
                                                  • Glenn Tillotson, SVP

                                                    Glenn is a Senior Vice President at Cempra Inc in Chapel Hill, USA. He is trained in medical microbiology and infectious diseases and almost 30 of pharmaceutical industry experience in various areas including clinical research, commercialization, scientific communications ...

                                                    See more See less
                                                  • Marilyn Roossinck, PhD

                                                    Dr. Roossinck received a PhD in 1986 from the University of Colorado School of Medicine in Microbiology and Immunology, studying Hepatitis B virus, on an National Institutes of Health fellowship. Following a postdoctoral fellowship at Cornell University, where she began studying ...

                                                    See more See less
                                                  • Bradley Ford, MD, PhD

                                                    Bradley Ford received his M.D. and Ph.D. (Physiology and Biophysics) degrees from SUNY Stony Brook, followed by a Clinical Pathology residency and postdoctoral training in basic and clinical microbiology at Washington University in St. Louis. His research interests include ...

                                                    See more See less
                                                  • Fred Russell Kramer, PhD

                                                    Fred Russell Kramer currently works at the Department of Microbiology, Biochemistry and Molecular Genetics, at the Public Health Research Institute of the New Jersey Medical School at Rutgers University. His laboratory's current current project is the design of extremely ...

                                                    See more See less
                                                  • John Thomas, PhD

                                                    Professor Emeritus John G. Thomas, PhD, is recognized as an "International Educator and Global Microbiologist " (www.globalbugs.com) having lectured in more than 43 countries while a clinical microbiologist in pathology (Professor), dentistry (Clinical Professor) and Graduate ...

                                                    See more See less
                                                  • James Snyder, PhD, DABMM, FAMM

                                                    James W. Snyder, Ph.D. is a professor in the Department of Pathology and Laboratory Medicine and Chief of Microbiology at the U of L Hospital. Dr. Snyder earned his Ph.D. in Biology (Medical Microbiology) from the University of Dayton. Dr. Snyder serves as the American Society ...

                                                    See more See less
                                                  • Neil Osheroff, PhD

                                                    Neil Osheroff received a Bachelor's Degree in Chemistry from Hobart College in 1974 followed by a Ph.D. in Biochemistry and Molecular Biology from Northwestern University in 1979. His doctoral dissertation on the mechanism of action of cytochrome c was under the direction of ...

                                                    See more See less
                                                  Help

                                                  General LabRoots Questions

                                                  For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                                                  Contact us

                                                  Virtual Events and Webinars

                                                  Supported Configurations

                                                  • Operating System Internet Explorer Firefox Chrome Safari
                                                    Vista IE8+ FF10+ Chrome15+
                                                    Windows 7 IE8+ FF10+ Chrome15+
                                                    Windows 8 IE10 FF10+ Chrome15+
                                                    Mac OS X   FF10+ Chrome15+ Safari5.1+
                                                  • Cookie settings: session cookies enabled
                                                  • Browser configuration must have JavaScript enabled
                                                  • Adobe Flash player 10.2 or later

                                                  To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                                  Internet Connection

                                                  • A minimum of 100Kbps is recommended for audio-only events
                                                  • A minimum of 300Kbps is recommended for speaker on-video events

                                                  Computer Equipment

                                                  • Screen Resolution: Minimum 1024x768
                                                  • Video Card: 65,000 colors minimum
                                                  • Sound card and speakers (or headphones) for hearing webcast in full format
                                                  • Audio Card: 16-bit minimum
                                                  • RAM: 512MB of free RAM

                                                  Firewall Protocol

                                                  • HTTP on port 80 or HTTPS on port 443
                                                  • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                                  • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                                  Work-At-Home Attendees

                                                  • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                                  For A Seamless Experience

                                                  When using a mobile device, FREE Mobile Apps are available:

                                                  - For viewing Webinars:

                                                  - For viewing Virtual Events

                                                  Attendee Guide

                                                  • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                                  Virtual Event and Webinar Support:

                                                  Continuing Education (CME/CE) Support

                                                  Loading Comments...
                                                  Show Resources